Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Drugs & Therapy Perspectives
Published in: Drugs & Therapy Perspectives 9/2023

18-08-2023 | Acne | Disease Management

Manage truncal acne and scarring the same as for facial acne, but more trunk-specific therapies are warranted

Author: Connie Kang

Published in: Drugs & Therapy Perspectives | Issue 9/2023

Login to get access

Abstract

Truncal acne is present in a significant proportion of patients with acne vulgaris, and impacts patients differently to facial acne. However, there is a distinct lack of literature on the management of truncal acne, and almost all treatment options are those studied and used in facial acne. Scarring from truncal acne is also treated the same as for facial acne scarring, mainly with lasers. Thus, further investigation into trunk-specific treatments and guidance will be useful.
Literature
1.
Daniele SG, Kim SR, Grada A, et al. Truncal acne and scarring: a comprehensive review of current medical and cosmetic approaches to treatment and patient management. Am J Clin Dermatol. 2023;24(2):199–223.CrossRefPubMed
2.
Tan J, Alexis A, Baldwin H, et al. Gaps and recommendations for clinical management of truncal acne from the personalising acne: consensus of experts panel. JAAD Int. 2021;5:33–40.CrossRefPubMedPubMedCentral
3.
4.
Kim BR, Chun MY, Kim SA, et al. Sebum secretion of the trunk and the development of truncal acne in women: do truncal acne and sebum affect each other? Dermatology. 2015;231(1):87–93.CrossRefPubMed
5.
Dagnelie M-A, Corvec S, Saint-Jean M, et al. Decrease in diversity of Propionibacterium acnes phylotypes in patients with severe acne on the back. Acta Derm Venereol. 2018;98(2):262–7.CrossRefPubMed
6.
Bond P, Smit DL, de Ronde W. Anabolic–androgenic steroids: how do they work and what are the risks? Front Endocrinol (Laussane). 2022;13:1059473.CrossRef
7.
Zamil DH, Perez-Sanchez A, Katta R. Acne related to dietary supplements. Dermatol Online J. 2020;26(8):2.CrossRef
8.
9.
Callender VD, Baldwin H, Cook-Bolden FE, et al. Effects of topical retinoids on acne and post-inflammatory hyperpigmentation in patients with skin of color: a clinical review and implications for practice. Am J Clin Dermatol. 2021;23(1):69–81.CrossRefPubMedPubMedCentral
10.
11.
Piccolo D, Kostaki D, Dianzani C, et al. Effective intense pulsed light protocol in the treatment of moderate to severe acne vulgaris of the chest and back. J Clin Aesthet Dermatol. 2022;15(3):22–5.PubMedPubMedCentral
Metadata
Title
Manage truncal acne and scarring the same as for facial acne, but more trunk-specific therapies are warranted
Author
Connie Kang
Publication date
18-08-2023
Publisher
Springer International Publishing
Published in
Drugs & Therapy Perspectives / Issue 9/2023
Print ISSN: 1172-0360
Electronic ISSN: 1179-1977
DOI
https://doi.org/10.1007/s40267-023-01018-9

Other articles of this Issue 9/2023

Drugs & Therapy Perspectives 9/2023 Go to the issue

Disease Management

Consider comorbidities, concomitant medications and organ function when treating chronic urticaria in older adults

Drug Reactions and Interactions

First reports of adverse drug reactions

Adis Summary of Research

Adis Summary of Research: Safety, Effectiveness, and Immunogenicity 6 Months After BNT162B2 mRNA Vaccine in Frail Nursing Home Residents

Adis Drug Q&A

Tapinarof cream 1% in plaque psoriasis: a profile of its use

Adis Drug Q&A

Linzagolix in moderate to severe symptoms of uterine fibroids: a profile of its use